In a case report published in the journal Primary Care Companion to Central Nervous System Disorders, three Penn State clinicians describe a patient who experienced serotonin toxicity after combining antidepressants and anti-anxiety medications and psilocybin.
Serotonin toxicity, or serotonin syndrome, occurs when high levels of serotonin build up on the body; the condition can be fatal.
Read more
Small clinical trials have shown that one or two doses of psilocybin, given in a therapeutic setting, can make dramatic and long-lasting changes in people suffering from treatment-resistant major depressive disorder, which typically does not respond to traditional antidepressants.
Click here for the link to this article.
Read more
Here’s an interview with five questions for physician Rachel Rackow, where she discusses the intersection of psychedelic-assisted therapy and palliative care.
Read more
Psychedelic nonprofit Unlimited Sciences announced the Psychedelic Info Line providing callers with fact-based information on psychedelics.
People are encouraged to call toll-free 1 (888) 210-3553 (Monday through Thursday from 8:00 a.m. – 5:00 p.m. MST or email.
Read more
Are psychedelics an antidote to pessimism?
Research indicates that psychedelic therapy can improve mental health outcomes by addressing the pessimism bias.
Read more
The connection between the psychedelic movement and Indigenous medicine is complex and multifaceted.
Indigenous-led Medicine conservation is biocultural conservation.
It is NOT an effort to simply preserve these medicines (and supply chains) – or their constituent molecules and/or specific habitat – but the entire ecological, social and cultural milieus within which they exist, and from which they cannot be separated without compromising the system as a whole.
Read more